WallStSmart
LIXT

Lixte Biotechnology Holdings Inc

NASDAQ: LIXT · HEALTHCARE · BIOTECHNOLOGY

$3.50
+0.00% today

Updated 2026-04-30

Market cap
$44.15M
P/E ratio
P/S ratio
20.35x
EPS (TTM)
$-1.26
Dividend yield
52W range
$1 – $6
Volume
0.0M

Lixte Biotechnology Holdings Inc (LIXT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-20.5%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-2.5%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$-0.33$3.90$3.84-1.5%
2025-11-12$-0.33$4.41$4.30-2.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.33
2025-09-30$-0.33
2025-06-30$0.00$-0.29
2025-03-31$-0.29
2024-12-31$-0.27
2024-09-30$-0.44
2024-06-30$-0.45
2024-03-31$-0.43
2023-12-31$-0.46
2023-09-30$-0.49
2023-06-30$-1.00
2023-03-31$-0.08

Frequently asked questions

Has Lixte Biotechnology Holdings Inc beaten earnings estimates?
Lixte Biotechnology Holdings Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does LIXT stock react to earnings?
LIXT stock has moved an average of -2.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.